Earnings Feed
Start Free
CELL GENESYS INC·4

Oct 15, 4:04 PM ET

VERMA INDER M 4

4 · CELL GENESYS INC · Filed Oct 15, 2009

Insider Transaction Report

Form 4
Period: 2009-10-14
CELL GENESYS INCCEGE
VERMA INDER M
Director
Transactions
  • Disposition to Issuer

    Common Stock

    2009-10-14−55,196→ 0 total
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $2.60Exp: 2018-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
    Exercise: $3.24Exp: 2017-01-31→ Common Stock (2,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy0

    2009-10-14−7,500→ 0 total
    Exercise: $10.39Exp: 2014-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
    Exercise: $1.81Exp: 2018-01-31→ Common Stock (2,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $5.02Exp: 2016-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
    Exercise: $56.26Exp: 2016-01-31→ Common Stock (2,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $8.81Exp: 2013-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $3.47Exp: 2017-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $5.35Exp: 2015-06-30→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
    Exercise: $10.39Exp: 2014-06-30→ Common Stock (2,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
    Exercise: $10.38Exp: 2013-06-02→ Common Stock (2,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
    Exercise: $12.88Exp: 2012-06-03→ Common Stock (2,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−7,500→ 0 total
    Exercise: $20.50Exp: 2011-06-29→ Common Stock (7,500 underlying)
  • Disposition to Issuer

    Stock Option (right to buy)

    2009-10-14−2,500→ 0 total
    Exercise: $17.00Exp: 2011-05-31→ Common Stock (2,500 underlying)
Footnotes (3)
  • [F1]Pursuant to the merger of Cell Genesys, Inc. with and into BioSante Pharmaceuticals, Inc. (the "Merger"), such shares were disposed of in exchange for 10,089 shares of BioSante common stock having a market value of $1.82 per share on the effective date of the Merger.
  • [F2]This option vested immediately on the day of grant.
  • [F3]This option was terminated for no consideration upon the effective time of the Merger.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT